Guilford Pharmaceuticals Inc. broke ground yesterday for its $20 million research-and-development building, bolstering Baltimore's attempt to market itself as a biotechnology hub.
The building will be in the Holabird Industrial Park, adjacent to Guilford's headquarters at 6611 Tributary St. In addition to top Guilford executives, the groundbreaking was attended by local officials including Mayor Kurt L. Schmoke, Baltimore Development Corp. President M. J. "Jay" Brodie and James D. Fielder, acting secretary of the Maryland Department of Business and Economic Development.
Guilford is a biopharmaceutical company that develops therapies for cancer and products to diagnose and treat neurological diseases, including Alzheimer's. It has 200 employees.
The new building is to be completed by May. Guilford is getting $3 million in state debt guarantees, and the city is providing up to $750,000 in low-interest loans.
The 76,000-square-foot building will be able to house more than 120 researchers. Guilford might add jobs because of product-development contracts it has with biotechnology companies.
Pub Date: 6/05/98